Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'OTHER', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 50}}, 'statusModule': {'overallStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2022-04-28', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-03', 'completionDateStruct': {'date': '2025-07', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2024-03-15', 'studyFirstSubmitDate': '2024-03-04', 'studyFirstSubmitQcDate': '2024-03-15', 'lastUpdatePostDateStruct': {'date': '2024-03-19', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2024-03-19', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'verify the difference in the monopodalic CMJ (countermovement jump test) of the diseased limb of subjects with ankle instability compared to the control group', 'timeFrame': 'Day 0', 'description': 'verify the difference in the monopodalic CMJ (countermovement jump test) value of the diseased limb of subjects with ankle instability compared to the control group at time 0'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Ankle Disease']}, 'descriptionModule': {'briefSummary': 'The study is, in accordance with current legislation, definable as a single-center interventional study with evaluations carried out at a single timeframe.\n\nThe objective of the study is to compare jumping performance between subjects with ankle instability and healthy volunteer subjects.\n\nIn particular, the primary objective is to verify the difference in the monopodalic CMJ value of the diseased limb of subjects with ankle instability compared to the control group at time 0.\n\nThe population is made up of patients suffering from ankle instability and a control group of healthy volunteers, divided as follows:\n\n25 subjects GROUP A: Study group: patients suffering from ankle instability\n\n25 subjects GROUP B: control group: healthy voluntary subjects not affected by ankle pathology', 'detailedDescription': 'Ankle sprains are one of the most common injuries during sports activity which often results in chronic instability of the ankle, characterized by a feeling of sagging more or less associated with pain with impairment of sports activity.\n\nNumerous authors have suggested that there is altered peripheral neuromuscular control in patients with ankle instability with limitations related to proprioception, neuromuscular control, or strength, leading to deficits not only of the ankle joint but of the entire inferior kinetic chain Jumping is a simple gesture, present in almost every sporting activity, and its evaluation has proven to be a reliable parameter in terms of partisan capacity.\n\nPatients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects.\n\nT0\n\n* Explanation of the study and written informed consent.\n* Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments.\n* AOFAS Rating Scales,\n* Tegner activity level\n* Vertical Jump Test (CMJ) using OptoGait platform using a battery of monopodalic jumps.\n* Drop jump using an OptoGait platform using a battery of monopodalic jumps\n* Side hop test using an OptoGait platform using a battery of monopod jumps'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '45 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Athletes of legal age (aged between 18 and 45 years inclusive) suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability (study group).\n* Athletes of legal age (aged between 18 and 45 years) who are not symptomatic for ankle diseases (control group)\n* Signing of the Informed Consent and consent to collaborate in all study procedures.\n\nExclusion Criteria:\n\n* Minors\n* Pregnant women (self-declaration)\n* patients with BMI ≥ 30\n* patients with orthopaedic, muscular and neuromuscular problems at the time of performing the jump\n* Non-acceptance of informed consent\n* Patients with previous unilateral or contralateral ankle reconstructive surgery'}, 'identificationModule': {'nctId': 'NCT06318494', 'acronym': 'Ankle-optoga', 'briefTitle': 'Analysis of Jumping in Patients With Ankle Instability (Ankle-optogait)', 'organization': {'class': 'OTHER', 'fullName': "I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio"}, 'officialTitle': 'Analysis of Jumping in Patients With Ankle Instability (Ankle-optogait)', 'orgStudyIdInfo': {'id': 'Ankle-optogait'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Patients suffering from ankle instability', 'interventionNames': ['Other: jumping performance']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Healthy volunteer subjects not affected by ankle pathology', 'interventionNames': ['Other: jumping performance']}], 'interventions': [{'name': 'jumping performance', 'type': 'OTHER', 'description': 'Patients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects.\n\nT0 Explanation of the study and written informed consent.\n\n* Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments.\n* AOFAS Rating Scales,\n* Tegner activity level\n* Vertical Jump Test (CMJ) by foot pedal', 'armGroupLabels': ['Healthy volunteer subjects not affected by ankle pathology', 'Patients suffering from ankle instability']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Milan', 'country': 'Italy', 'facility': 'Istituto Clinico San Siro', 'geoPoint': {'lat': 45.46427, 'lon': 9.18951}}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': "I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio", 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}